Endothelial dysfunction induced by antibodies against angiotensin AT 1 receptor in immunized rats

Acta Pharmacologica Sinica

Volumn 31, Issue 10, 2010, Pages 1381-1388

  Zhang, Su Li ^a   Du, Yun Hui ^b   Wang, Jin ^a   Yang, Li Hong ^a   Yang, Xiao Li ^c   Zheng, Rong Hua ^a   Wu, Ye ^a   Wang, Ke ^a   Zhang, Ming Sheng ^a   Liu, Hui Rong ^a,b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Central Hospital of Taiyuan   (China)

Author keywords

angiotensin II type 1 receptor; antibodies; endothelial intercellular adhesion molecule 1; endothelin 1; endothelium; endothelium dependent vasodilatation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; ENDOTHELIN 1; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONFOCAL MICROSCOPY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NONHUMAN; RAT; THORACIC AORTA; TRANSMISSION ELECTRON MICROSCOPY; VASODILATATION;

ANIMALS; AORTA, THORACIC; AUTOANTIBODIES; CAPILLARIES; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE-1; L-LACTATE DEHYDROGENASE; MALE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; UMBILICAL VEINS; VASODILATION;

EID: 77957738703     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.144     Document Type: Article

References (34)

1. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.
2. Roberts JM. Angiotensin-1 receptor autoantibodies: a role in the pathogenesis of preeclampsia? Circulation 2000;101:2335-7.
3. Fleming S. Malignant hypertension - the role of the paracrine reninangiotensin system. J Pathol 2000;192:135-9.
4. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, et al. Patients with preeclampsia develop agonistic antibodies against the angiotensin AT1 receptor. J Clin Inves 1999;103:945-52.
5. Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD, et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 2006;4:67-78.
6. Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT, Cheng LX. Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res 2002;25:641-6.
7. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Kintscher DR, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005;352:558-69.
8. Fu ML, Leung PS, Wallukat G, Bergström G, Fu H, Schulze W, et al. Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 1999;8:317-24.
9. Sun YX, Zhang HY, Wei YM, Zhu F, Wang M, Liao YH. The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension. Chin Med J (Engl) 2008;121:43-8.
10. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003;107:1632-9.
11. Irani RA, Zhang Y, Zhou CC, Blackwell SC, Hicks MJ, Ramin SM, et al. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 2010;55:1246-53.
12. Bobst SM, Day MC, Gilstrap LC 3rd, Xia Y, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 2005;18:330-6.
13. Chen Q, Chen L, Liu B, Vialli C, Stone P, Ching LM, et al. The role of autocrine TGFbeta1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre-eclampsia. J Pathol 2010 Jan 21. doi: 10.1002/path.2690.
14. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endotheliumdependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009;157:527-36.
15. Suzuki H, Eguchi K, Ohtsu H, Higuchi S, Dhobale S, Frank GD, et al. Activation of endothelial nitric oxide synthase by the angiotensin II type 1 receptor. Endocrinology 2006;147:5914-20.
16. Newton CR, Curran B, Victorino GP. Angiotensin II type 1 receptor activation increases microvascular permeability via a calcium dependent process. J Surg Res 2005;123:33-9.
17. La Marca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, et al. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 2009;54:905-9.
18. Yang X, Wang F, Chang H, Zhang S, Yang L, Wang X, et al. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens 2008;26:1629-35.
19. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64:313-20.
20. Vasudevan H, Nagareddy PR, John H. Gonadectomy prevents endothelial dysfunction in fructose-fedmale rats, a factor contributing to the development of hypertension. Am J Physiol Heart Circ Physiol 2006;291: H3058-H3064.
21. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008;10:1115-26.
22. Houston MC. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog Cardiovasc Dis 2005;47:396-49.
23. Walsh SW. What causes endothelial cell activation in preeclamptic women? Am J Pathol 2006;169:1104-6.
24. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, et al. AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000;101:2382-7.
25. 2+ mobilization through angiotensin receptor activation. Circulation 2004;110:1612-9.
26. Fu ML, Leung PS, Wallukat G, Bergström G, Fu H, Schulze W, et al. Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 1999;8:317-24.
27. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
28. Moldes O, Sobrino T, Millán M, Castellanos M, Pérez de la Ossa N, Leira R, et al. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA. Stroke 2008;39:2006-10.
29. Ariza AC, Bobadilla NA, Halhali A. Endothelin 1 and angiotensin II in preeclampsia. Rev Invest Clin 2007;59:48-56.
30. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996;175:1668-74.
31. Mizia-Steck K. Cytokines and adhesive molecules in detection of endothelial dysfunction. Pharmacol Rep 2006;58 Suppl: 21-32.
32. Intengan HD, Schiffrin EL. Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats. Hypertension 2000;35:1221-5.
33. Qiu Y, Zhu F, Liao YH, Li ZZ, Wang M. Association between positive autoantibodies against AT1-receptor and cardiac remodeling in patients with hypertension. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35:1141-4.
34. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, et al. Direct evidence for a β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-29.